Thermo Fisher stock steadies near $504 as Danaher’s $9.9 billion Masimo deal rattles life-sciences names
Thermo Fisher shares dipped $0.43 to $504.39 Tuesday afternoon, little changed despite renewed deal activity in the sector. The company recently priced $3.8 billion in debt to fund its $8.9 billion Clario acquisition, with shares down about 6% since last week. Danaher fell 3.4% after agreeing to buy Masimo for $9.9 billion. Investors await Agilent’s Feb. 25 results and Thermo Fisher’s April 22 earnings.